Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 936-073-9 | CAS number: 1253791-42-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- propan-2-yl 2-bromo-3-cyclopentyl-1-methyl-1H-indole-6-carboxylate
- EC Number:
- 936-073-9
- Cas Number:
- 1253791-42-2
- Molecular formula:
- C18 H22 Br N O2
- IUPAC Name:
- propan-2-yl 2-bromo-3-cyclopentyl-1-methyl-1H-indole-6-carboxylate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): CD00006062XX
- Physical state: white powder:
- Storage condition of test material: room temperature
- Lot/batch No.: BIC 11008957
- Expiration date of the lot/batch: 31 March 2007
- Composition / Purity : Purity was 101.7 %
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Jackson Laboratories, Bar Harbor, ME 04609
- Age at study initiation: 10 weeks
- Weight at study initiation: 20 - 24 g
- Housing: Animals were group housed ( 5 per cage ).
- Diet (e.g. ad libitum): Animals had access to Certified Rodent Diet 7012C ad libitum.
- Water (e.g. ad libitum): Tap water was available ad libitum, via water bottles.
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23.3 - 27.2
- Humidity (%): 28 - 54
- Photoperiod (hrs dark / hrs light): 12 : 12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Three consecutive concentrations (2.5 %,1.0 %;0.5 % )
- No. of animals per dose:
- 5 animals per dose
- Details on study design:
- Solubility Test : Based on the solubility test, acetone/ olive oil was selected as the vehicle and the highest concentration of the test article that
could be achieved was 2.5 % (w/v). Therefore, the dose levels selected for the assay were 0.5, 1.0 and 2.5 % (w/v). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The positive control, 35 % (v/v) HCA, resulted in a stimulation index (SI) of 9.42.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: Concentration 0.5 % SI = 1.02 Concentration 1.0 % SI = 0.91 Concentration 2.5 % SI = 1.49
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Concentration 0.5 % DPM ~ 345 Concentration 1.0 % DPM ~ 306 Concentration 2.5 % DPM ~ 501
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- A test material is considered to have skin sensitizing activity if, at one or more concentrations, it induces a 3-fold or greater increase in proliferative
activity relative to the concurrent vehicle treated control group. Thus, a stimulation index (SI) of 3.0 or greater is regarded as a positive response.
Although the dosing solution concentration were not verified, treatment with CD00006062XX at nominal concentrations up to 2.5 % did not result in an SI of 3 or greater.
Therefore, based on the data from this study, CD00006062XX is not considered to have skin sensitizing potential. - Executive summary:
Objective
The purpose of this study was to determine if CD00006062XX would induce a hypersensitivity response in mice as measured by the proliferation of lymphocytes in the draining nodes.
Methods
Five groups of CBA/J female mice were treated on the dorsal surface of both ears once per day for 3 days with CD00006062XX at 0.5, 1.0 and 2.5 % with the vehicle (acetone/olive oil (AOO)), or with the positive control ( 35 % Hexylcinnamaldehyd(HCA)) . On day 6, the mice were injected , i.v., with 20µCi of ³H-thymidine in sterile saline. Five hours later, the mice were euthanized and the draining auricular lymph nodes were removed. The lymph node cells were percipitated with 5 % trichloroacetic acid (TCA) and the pellets counted in a ß-scintillation counter to determine incorporation of the ³H-thymidine .
Results
No erythema or edema was noted in any of the groups treated with AOO or CD00006062XX. The positive control, HCA, resulted in very slight erythema on Day 3 through 5. Also the ears of the mice treated with the positive control appeared wet on day 2 through day 5. There were no other findings.
At termination, the lymph node from the mice treated with CD00006062XX and AOO were slightly enlarged in size but normal in appearance. The lymph node from the mice in the HCA group were enlarged but were otherwise normal in appearance.
The positive control resulted in a stimulation index of 9.2.
Exposure to CD00006062XX at 0.5, 1 and 2.5 % (w/v) resulted in stimulation indices of 1.02, 0.91 and 1.49, respectively. There were no statistically significant differences found when the mean log DPM for any of the test article treatment groups was compared to the vehicle group.
Conclusion
A test material is considered to have skin sensitizing activity if, at one or more concentrations, it induces a 3-fold or greater increase in proliferative activity relative to the concurrent vehicle treated control group. Thus, a stimulation index (SI) of 3.0 or greater is regarded as a positive response. Although the dosing solution concentration were nor verified, treatment with CD00006062XX at nominal concentrations up to 2.5 % did not result in an SI of 3 or greater. Therefore, based on the data from this study, CD00006062XX is not considered to have skin sensitizing potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
